Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia

November 2019

Baqsimi (bak-SEE-mee) and Gvoke (JEE-vohk) are new glucagon Rxs that will be game changers for treating severe hypoglycemia.

Quick response is key. Severe hypoglycemia causes confusion, seizures, and loss of consciousness...increasing risk of injury and death.

Baqsimi is INTRANASAL glucagon. It's a ready-to-use powder sprayed in one nostril...and is absorbed without inhaling.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote